(Q33718749)

28 July 2017

title

Prospective study evaluating oncological safety of axillary reverse mapping (English)

1 reference

28 July 2017

Eduardo Schunemann

1

1 reference

28 July 2017

Maíra Teixeira Dória

2

1 reference

28 July 2017

Janiceli Blanca Carlotto Hablich Silvestre

3

1 reference

28 July 2017

Plínio Gasperin

4

1 reference

28 July 2017

Teresa Cristina Santos Cavalcanti

5

1 reference

28 July 2017

Vinicius Milani Budel

6

1 reference

28 July 2017

publication date

6 March 2014

1 reference

Annals of Surgical Oncology

28 July 2017

published in

1 reference

28 July 2017

volume

21

1 reference

28 July 2017

issue

7

1 reference

28 July 2017

page(s)

2197-2202

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

copyright license

start time

6 March 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

The efficacy of arm node preserving surgery using axillary reverse mapping for preventing lymphedema in patients with breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Lymphedema and breast cancer: a review of the literature.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Axillary reverse mapping for breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4047480

Lymphedema in breast cancer survivors: assessment and information provision in a specialized breast unit.

21 June 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Feasibility of axillary reverse mapping during sentinel lymph node biopsy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Extensive nodal disease may impair axillary reverse mapping in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Axillary reverse mapping in breast cancer: can we spare what we find?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Axillary reverse mapping: mapping and preserving arm lymphatics may be important in preventing lymphedema during sentinel lymph node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Axillary reverse mapping: a prospective study in women with clinically node negative and node positive breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Selective axillary dissection after axillary reverse mapping to prevent breast-cancer-related lymphoedema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Axillary reverse mapping for preventing lymphedema in axillary lymph node dissection and/or sentinel lymph node biopsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Axillary reverse mapping using a fluorescence imaging system in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

ARM: axillary reverse mapping - the need for selection of patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3626-5

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24599413

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24599413

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24599413

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1245/S10434-014-3626-5

1 reference

Dimensions Publication ID

28 July 2017

0 references

1 reference

28 July 2017

1 reference